Patients with melanoma and diabetes benefit from metformin treatment

Br J Dermatol. 2023 Jan 23;188(1):e5. doi: 10.1093/bjd/ljac150.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus*
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents
  • Melanoma* / chemically induced
  • Metformin* / adverse effects

Substances

  • Metformin
  • Hypoglycemic Agents